Download PDF
Thromb Haemost 1994; 72(04): 647
DOI: 10.1055/s-0038-1648931
Letter to the Editor
Schattauer GmbH Stuttgart

Plasma Resistance to Activated Protein C in Venous and Arterial Thrombosis

M Cushman
Department of Pathology, University of Vermont, Burlington, VT, USA
,
F Bhushan
Department of Pathology, University of Vermont, Burlington, VT, USA
,
E Bovill
Department of Pathology, University of Vermont, Burlington, VT, USA
,
R Tracy
Department of Pathology, University of Vermont, Burlington, VT, USA
› Author Affiliations
Further Information

Publication History

Received 09 May 1994

Accepted after resubmission 09 June 1994

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
    CrossrefPubMedGoogle Scholar
  • 2 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-1400
    CrossrefPubMedGoogle Scholar
  • 3 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993
    PubMedGoogle Scholar
  • 4 Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
    CrossrefPubMedGoogle Scholar
  • 5 Cadroy Y, Sié P, Boneu B. Frequency of a defective response to activated protein C in patients with a history of venous thrombosis. Blood 1994; 83: 2008-2009
    PubMedGoogle Scholar
  • 6 Lindblad B, Svensson PJ, Dahlbäck B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet 1994; 343: 917
    CrossrefPubMedGoogle Scholar
  • 7 Halbmayer WM, Haushofer A, Schön R, Fischer M. The prevalence of poor anticoagulant response to activated protein C among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coag Fibri-nol 1994; 5: 51-57
    CrossrefPubMedGoogle Scholar